Different bacterial species selectively induce TH1 cells
不同菌种选择性诱导TH1细胞
基本信息
- 批准号:7057845
- 负责人:
- 金额:$ 13.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:EnterobacteriaceaeEnterococcusEscherichia colibacterial antigensbacterial diseasecellular immunitycolitisenzyme linked immunosorbent assayflow cytometryfluorescent in situ hybridizationgenetic straingenetic susceptibilityhelper T lymphocytehost organism interactionimmune adherence reactionimmune responseinflammationlaboratory mouseleukocyte activation /transformationphenotypepolymerase chain reactionserology /serodiagnosistissue /cell culturevirulence
项目摘要
DESCRIPTION (provided by applicant):
Chronic relapsing intestinal inflammation appears to be mediated by dysregulated innate and acquired immune responses to commensal (nonpathogenic) enteric bacteria in genetically predisposed individuals. We hypothesize that (1) various non-pathogenic commensal bacteria induce distinct disease phenotypes in genetically susceptible hosts due to either regionally restricted mucosal immune responses to bacterial antigens or b. selective epithelial adherence/ invasion in different regions of the intestine, and (2) a discrete number of E.faecalis antigens induce dysregulated T cell immune responses, leading to the induction and perpetuation of chronic intestinal inflammation. These hypotheses are addressed in the following Specific aims: 1. Identify the mechanisms by which E.faecalis and E. coli, alone and in combination, induce different disease phenotypes in the same genetically susceptible host, the IL-10-/- mouse, by:
a. Comparing virulence factors (epithelial adherence and invasion) of E. coli and E.faecalis shown to differentially induce distinct disease phenotypes in monoassociated IL-10-/- mice to known adherent/ invasive E. coli (AIEC) strains isolated from human Crohn's disease patients, and randomly isolated commensal E.coli and E.faecalis strains from SPF IL-10-/- mice with colitis and WT mice.
b. Determining in vivo regional differences in mucosal adherence and invasion by each bacterial species in IL-10-/- mice co-colonized with these two bacterial species.
c. Investigating the ability of adoptively transferred CD4+ cells isolated from colitic IL-10-/'- mice monoassociated with E. coli or E.faecalis to induce regionally specific intestinal inflammation and variable disease kinetics in immunodeficient mice colonized with either or both bacterial species. 2. Identify dominant E.faecalis antigens activating T cells in monoassociated IL-10-/- mice by:
a. Determining the dominant antigens (identified in an expression library screened by serologic responses) that induce interferon-gamma (IFN-gamma) responses in CD4+ T cells from the mesenteric lymph nodes of E.faecalis - monoassociated IL-10-/- mice with colitis.
b. Identifying the specific epitope(s) involved in immune activation and subsequent perpetuation of intestinal inflammation in IL-10-/- mice through truncation mutagenesis.
c. Determining if recombinant nonpathogenic bacteria engineered to expressing the dominant E.faecalis epitope can induce T cell - mediated colitis and duodenitis.
描述(由申请人提供):
慢性复发性肠炎似乎是由遗传易感个体对共生(非致病)肠道细菌的先天性和获得性免疫反应失调所介导的。我们假设(1)各种非致病共生细菌在遗传易感宿主中诱导不同的疾病表型,这是由于对细菌抗原的区域性限制的黏膜免疫反应或B.肠道不同区域的选择性上皮黏附/侵袭,以及(2)离散数量的粪肠球菌抗原诱导失调的T细胞免疫反应,导致慢性肠炎的诱导和持续。这些假说针对以下具体目标:1.确定粪肠球菌和大肠杆菌单独和联合在同一遗传易感宿主IL-10-/-小鼠中诱导不同疾病表型的机制:
A.比较大肠杆菌和粪肠球菌的毒力因素(上皮黏附和侵袭),发现它们在单相关IL-10-/-小鼠中不同地诱导不同的疾病表型,与从人类克罗恩病患者中分离的已知黏附/侵袭性大肠杆菌(AIEC)菌株,以及从患有结肠炎和WT小鼠的SPF IL-10-/-小鼠中随机分离的共生大肠杆菌和粪肠球菌菌株进行比较。
B.在体内确定与这两种细菌共存的IL-10-/-小鼠中每种细菌对粘膜黏附和侵袭的区域性差异。
C.研究从与大肠杆菌或粪肠球菌单一相关的结肠炎IL-10-/‘-小鼠体内过继转移的CD4+细胞在免疫缺陷小鼠中诱导局部特异性肠炎和可变疾病动力学的能力。2.通过以下方法确定激活单相关IL-10-/-小鼠T细胞的优势粪肠球菌抗原:
A.确定在患有结肠炎的粪肠球菌单相关IL-10-/-小鼠的肠系膜淋巴结中诱导CD4+T细胞产生干扰素-γ反应的主要抗原(在通过血清学反应筛选的表达文库中鉴定)。
B.通过截断突变鉴定参与IL-10-/-小鼠免疫激活和随后的肠道炎症持续存在的特定表位(S)。
C.确定重组非致病细菌是否能诱导T细胞介导的结肠炎和十二指肠炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANDRA C KIM其他文献
SANDRA C KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANDRA C KIM', 18)}}的其他基金
Adherent Escherichia coli and associated virulence genes in children with IBD
IBD 儿童中的粘附性大肠杆菌和相关毒力基因
- 批准号:
7920885 - 财政年份:2009
- 资助金额:
$ 13.32万 - 项目类别:
Adherent Escherichia coli and associated virulence genes in children with IBD
IBD 儿童中的粘附性大肠杆菌和相关毒力基因
- 批准号:
7708474 - 财政年份:2009
- 资助金额:
$ 13.32万 - 项目类别:
Different bacterial species selectively induce TH1 cells
不同菌种选择性诱导TH1细胞
- 批准号:
6928302 - 财政年份:2005
- 资助金额:
$ 13.32万 - 项目类别:
Different bacterial species selectively induce TH1 cells
不同菌种选择性诱导TH1细胞
- 批准号:
7446562 - 财政年份:2005
- 资助金额:
$ 13.32万 - 项目类别:
Different bacterial species selectively induce TH1 cells
不同菌种选择性诱导TH1细胞
- 批准号:
7244996 - 财政年份:2005
- 资助金额:
$ 13.32万 - 项目类别:
Different bacterial species selectively induce TH1 cells
不同菌种选择性诱导TH1细胞
- 批准号:
7637737 - 财政年份:2005
- 资助金额:
$ 13.32万 - 项目类别:
相似国自然基金
草地贪夜蛾共生细菌Enterococcus casseliflavus来源的色氨酸介导宿主氯虫苯甲酰胺解毒代谢机制
- 批准号:32302393
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肥胖儿童MAFLD 患者肠道 Enterococcus 菌属的分离培养与致病作用及机制研究
- 批准号:2022JJ40668
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
家蚕肠道微生物肠球菌(Enterococcus)对产丝量的影响及机制研究
- 批准号:32102615
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
家蚕肠道微生物肠球菌(Enterococcus)对产丝量的影响及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
参黄膏贴敷神阙穴对POI Enterococcus介导的IL-1R1/MyD88通路的作用机制研究
- 批准号:81973756
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
Enterococcus faecium H1激发霍乱弧菌在肠道环境条件下VPI-1/TCP毒力岛水平转移的分子机制
- 批准号:81873969
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Enterococcus faecium EF1 调节新生仔猪空肠黏膜稳态的TLRs信号通路
- 批准号:31460607
- 批准年份:2014
- 资助金额:50.0 万元
- 项目类别:地区科学基金项目
我国中高纬度地区冷水鱼肠道乳酸菌多样性、系统发育及优势种群Enterococcus的遗传多态性研究
- 批准号:31360001
- 批准年份:2013
- 资助金额:49.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Structural Characterisation of Bacteriophage Proteins Involved in Host Hijacking of Enterococcus Species
参与肠球菌宿主劫持的噬菌体蛋白的结构表征
- 批准号:
BB/Z515188/1 - 财政年份:2024
- 资助金额:
$ 13.32万 - 项目类别:
Fellowship
Canada_IPAP Antimicrobial-resistant Enterococcus faecium in the One Health context in the UK and Canada
Canada_IPAP 英国和加拿大 One Health 背景下的耐药屎肠球菌
- 批准号:
BB/X012727/1 - 财政年份:2023
- 资助金额:
$ 13.32万 - 项目类别:
Research Grant
Second Messenger Nucleotides of Enterococcus faecalis
粪肠球菌第二信使核苷酸
- 批准号:
10676471 - 财政年份:2023
- 资助金额:
$ 13.32万 - 项目类别:
Understanding cell surface recognition by bacteriophages to engineer novel therapeutics targeting Enterococcus cecorum, an emerging poultry pathogen
了解噬菌体的细胞表面识别,以设计针对盲肠肠球菌(一种新兴的家禽病原体)的新型疗法
- 批准号:
2881108 - 财政年份:2023
- 资助金额:
$ 13.32万 - 项目类别:
Studentship
Mechanism Of Enterococcus Faecalis Nitro Drug Metabolism And In Vivo Implications
粪肠球菌硝基药物代谢机制及其体内影响
- 批准号:
10511022 - 财政年份:2022
- 资助金额:
$ 13.32万 - 项目类别:
Deciphering the genetic basis of differential antibiotic efficacy in Enterococcus faecalis endocarditis
破译抗生素对粪肠球菌心内膜炎疗效差异的遗传基础
- 批准号:
10597129 - 财政年份:2022
- 资助金额:
$ 13.32万 - 项目类别:
Novel cell division mechanisms in round bacteria: Enterococcus faecalis and Neisseria gonorrhoeae as model organisms
圆形细菌中的新型细胞分裂机制:粪肠球菌和淋病奈瑟菌作为模式生物
- 批准号:
RGPIN-2018-04257 - 财政年份:2022
- 资助金额:
$ 13.32万 - 项目类别:
Discovery Grants Program - Individual
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
肠球菌独特的假设 EF1909 在内在 β-内酰胺耐药性中的作用
- 批准号:
10569041 - 财政年份:2022
- 资助金额:
$ 13.32万 - 项目类别:
Context-specific modulation of Clostridioides difficile virulence by Vancomycin-resistant Enterococcus faecium
耐万古霉素屎肠球菌对艰难梭菌毒力的特定调节
- 批准号:
10629341 - 财政年份:2022
- 资助金额:
$ 13.32万 - 项目类别:
Second Messenger Nucleotides of Enterococcus faecalis
粪肠球菌第二信使核苷酸
- 批准号:
10672673 - 财政年份:2022
- 资助金额:
$ 13.32万 - 项目类别: